Bio Preservation Market Analysis Report 2025: Growth in Regenerative Medicine and Increasing Demand for Advanced Cell and Gene Therapy Storage Solutions - Forecast to 2030

The Global Bio Preservation Market presents growth opportunities driven by the rising demand for organ transplants and regenerative medicine, expansion of biobanks, and AI integration to optimize preservation processes. However, challenges include high costs of advanced techniques and equipment.

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Bio Preservation Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.

The Global Bio Preservation Market, valued at USD 2.10 Billion in 2024, is projected to experience a CAGR of 9.90% to reach USD 3.70 Billion by 2030

Biopreservation refers to methods designed to maintain the viability and functionality of biological samples, including cells, tissues, and organs, outside their native environment for prolonged periods. This market growth is primarily supported by the escalating demand for organ transplants and the expanding scope of regenerative medicine research. The increasing establishment of biobanks globally also serves as a key driver.



Key Market Drivers

Advancements in regenerative medicine and cell and gene therapies represent a significant driver for the global biopreservation market, necessitating sophisticated methods to preserve delicate biological materials. The expansion of these therapeutic areas, offering novel treatments for previously intractable diseases, directly fuels the demand for high-quality preservation and storage solutions for cells, tissues, and genetic constructs.

These innovative therapies rely heavily on maintaining the viability and integrity of living cells from research to clinical application. According to the Alliance for Regenerative Medicine, in 2024, investments in the cell and gene therapy sector reached $15.2 billion, demonstrating a 30% growth compared to 2023. This substantial financial commitment underscores the escalating pipeline of therapies requiring robust biopreservation infrastructure.

Key Market Challenges

The challenging factor explicitly identified in the overview is the substantial cost associated with advanced biopreservation techniques and specialized equipment. This significant financial burden directly impedes the growth of the Global Bio Preservation Market by presenting considerable barriers to both initial setup and sustained operation for many organizations.

The high cost encompasses the acquisition of specialized equipment, such as ultra-low temperature freezers and advanced cryopreservation systems, along with recurring expenses for liquid nitrogen, cryoprotective agents, and highly skilled personnel. Such extensive investment demands often exceed the budgetary allocations of smaller research institutions, emerging biobanks, and even some larger entities.

Key Market Trends

The integration of Artificial Intelligence (AI) is a pivotal trend transforming the Global Bio Preservation Market by optimizing complex processes and enhancing sample integrity. AI algorithms analyze extensive datasets from cryopreservation protocols and post-preservation viability, identifying optimal conditions and predicting outcomes, thereby refining preservation methodologies.

For instance, according to The University of Manchester, in September 2024, scientists developing a machine learning program for cryoprotectant discovery reduced the amount of conventional cryoprotectant required for blood storage by introducing newly identified molecules. This demonstrates AI's direct impact on improving preservation techniques.

Key Attributes:

Report AttributeDetails
No. of Pages185
Forecast Period2024 - 2030
Estimated Market Value (USD) in 2024$2.1 Billion
Forecasted Market Value (USD) by 2030$3.7 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal


Report Scope:

Key Market Players Profiled:

  • BioCision LLC
  • BioLife Solutions Inc.
  • ThermoGenesis Holdings, Inc.
  • Custom Biogenic Systems Inc.
  • Lifeline Scientific Inc.
  • Merck KGaA KGaA
  • Princeton CryoTech Inc.
  • VWR International, LLC
  • Azenta US Inc.
  • DSM-Firmenich N.V.

By Product:

  • Equipment
  • Media
  • LIMS

By Application:

  • Regenerative Medicine
  • Bio-banking
  • Drug Discovery

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/6dcxpr

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood, Senior  Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900